StockNoteStockNote
Dak Lak Pharmaceutical - Medical Supplies Joint Stock Company (DBM), formerly known as Dak Lak Pharmaceutical Company, was established in 1976. The company officially operates under the model of a joint stock company since 2009. Dak Lak Pharmaceutical – Medical Supplies Joint Stock Company is one of the companies specializing in the distribution of pharmaceutical products and medical supplies. DBM main business activities in 02 provinces: Dak Lak and Dak Nong. DBM has been traded on the UPCOM market since December 2009.
DBM currently has a market capitalization of roughly VND 43 billion, placing it in the small-cap group on the Vietnamese stock market. Its current P/E of 12,2x is 25% above its own 6-year average (9,8x), suggesting the stock is trading richer than its historical norm. P/B stands at 0,8x, 12% below its multi-year average of 0,9x. Return on equity (ROE) is at 6,8%, up from 4,1% the year before. Its debt-to-equity ratio of 0x is low, reflecting a conservative capital structure. In 2025, revenue grew 3% year-on-year while after-tax profit grew 66%.
This note is generated automatically from the stock's real financial data, for reference only — not investment advice.
Unit: VND billion. Growth (%) vs. previous period.
Unit: VND billion. Year-end values; current year uses latest session.
Unit: x. Financial debt over shareholders' equity.
Data aggregated from cafef.vn and VNDirect, for reference only, not investment advice.